These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3192313)

  • 1. The effect of hemodialysis on whole blood, plasma and erythrocyte viscosity.
    Wink J; Vaziri ND; Barker S; Hyatt J; Ritchie C
    Int J Artif Organs; 1988 Sep; 11(5):340-2. PubMed ID: 3192313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renal replacement therapy on viscosity in end-stage renal disease patients.
    Feriani M; Kimmel PL; Kurantsin-Mills J; Bosch JP
    Am J Kidney Dis; 1992 Feb; 19(2):131-9. PubMed ID: 1739094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythropoietin administration on blood and plasma viscosity in hemodialysis patients.
    Vaziri ND; Ritchie C; Brown P; Kaupke J; Atkins K; Barker S; Hyatt J
    ASAIO Trans; 1989; 35(3):505-8. PubMed ID: 2597519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete correction of renal anemia by recombinant human erythropoietin.
    Ludat K; Paulitschke M; Riedel E; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S42-9. PubMed ID: 10746805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain.
    Fathallah-Shaykh SA; Brooks ER; Langman CB; Kensey KR
    Pediatr Nephrol; 2006 Aug; 21(8):1179-84. PubMed ID: 16721594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
    Samoĭlov MV; Zakharchenko VN; Larionov SM; Naumov AG; Danilkov AP; Zakharova VD; Ivleva AI; Kudriavtsev IuV; Surikova TP
    Urol Nefrol (Mosk); 1993; (4):34-7. PubMed ID: 8310565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recharging red blood cell surface by hemodialysis.
    Kliche K; Gerth U; Pavenstädt H; Oberleithner H
    Cell Physiol Biochem; 2015; 35(3):1107-15. PubMed ID: 25659423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione peroxidase activity in patients with renal disorders.
    El-Far MA; Bakr MA; Farahat SE; Abd El-Fattah EA
    Clin Exp Nephrol; 2005 Jun; 9(2):127-31. PubMed ID: 15980946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The passage of a hemodialysis filter affects hemorheology, red cell shape, and platelet aggregation.
    Reinhart WH; Cagienard F; Schulzki T; Venzin RM
    Clin Hemorheol Microcirc; 2014; 57(1):49-62. PubMed ID: 24004555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in whole blood viscosity at low shear rates correlate with intravascular volume changes during hemodialysis.
    Kim W; Park SK; Kang KP; Lee DH; Kim SY; Jung JM; Cho YI
    Int J Artif Organs; 2012 Jun; 35(6):425-34. PubMed ID: 22669590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients.
    Huang KC; Yang CC; Hsu SP; Lee KT; Liu HW; Morisawa S; Otsubo K; Chien CT
    Kidney Int; 2006 Jul; 70(2):391-8. PubMed ID: 16760903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of heart rate variability parameters in nondiabetic hemodialysis patients.
    Tong YQ; Hou HM
    Am J Nephrol; 2007; 27(1):63-9. PubMed ID: 17259695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I; Bladek K; Bulikowski W
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in whole blood viscosity during hemodialysis and mortality in patients with end-stage renal disease.
    Jung JH; Chae YJ; Lee DH; Cho YI; Ko MM; Park SK; Kim W
    Clin Hemorheol Microcirc; 2017; 65(3):285-297. PubMed ID: 27767962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin alert: risks of high hematocrit hemodialysis.
    Shinaberger JH; Miller JH; Gardner PW
    ASAIO Trans; 1988; 34(3):179-84. PubMed ID: 3196506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis.
    Martínez M; Vayá A; Alvariño J; Barberá JL; Ramos D; López A; Aznar J
    Clin Hemorheol Microcirc; 1999; 21(1):1-6. PubMed ID: 10517483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modifications of hemorheologic parameters in the course of hemodialysis in chronic renal insufficiency].
    Houbouyan L; Stoltz JF; Beauchet A; Consoli N; Prinseau J; Baglin A; Goguel A
    J Mal Vasc; 1994; 19(2):132-6. PubMed ID: 8077862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.